AAAAAA
Results:
1-18
|
Results: 18
Authors:
Bernhard, J
Beaufrere, B
Laville, M
Fouque, D
Citation: J. Bernhard et al., Adaptive response to a low-protein diet in predialysis chronic renal failure patients, J AM S NEPH, 12(6), 2001, pp. 1249-1254
Authors:
Thurlimann, B
Price, KN
Castiglione, M
Coates, AS
Goldhirsch, A
Gelber, RD
Forbes, J
Holmberg, S
Veronesi, A
Bernhard, J
Zahrieh, D
Citation: B. Thurlimann et al., Randomized controlled trial of ovarian function suppression plus tamoxifenversus the same endocrine therapy plus chemotherapy: is chemotherapy necessary for premenopausal women with node-positive, endocrine-responsive breast cancer? First results of International Breast Cancer Study Group Trial 11-93, BREAST, 10, 2001, pp. 130-138
Authors:
Coates, AS
Hurny, C
Peterson, HF
Bernhard, J
Castiglione-Gertsch, M
Gelber, RD
Goldhirsch, A
Citation: As. Coates et al., Quality of life scores predict outcome in metastatic but not in early breast cancer, BREAST, 10, 2001, pp. 164-170
Authors:
Bernhard, J
Lowy, A
Maibach, R
Hurny, C
Citation: J. Bernhard et al., Response shift in the perception of health for utility evaluation: an explorative investigation, EUR J CANC, 37(14), 2001, pp. 1729-1735
Authors:
Bernhard, J
Sullivan, M
Hurny, C
Coates, AS
Rudenstam, CM
Citation: J. Bernhard et al., Clinical relevance of single item quality of life indicators in cancer clinical trials, BR J CANC, 84(9), 2001, pp. 1156-1165
Authors:
Kiebert, G
Wait, S
Bernhard, J
Bezjak, A
Cella, D
Day, R
Houghton, J
Moinpour, C
Scott, C
Stephens, R
Citation: G. Kiebert et al., Practice and policy of measuring quality of life and health economics in cancer clinical trials: A survey among co-operative trial groups, QUAL LIFE R, 9(10), 2000, pp. 1073-1080
Authors:
Morant, R
Bernhard, J
Maibach, R
Borner, M
Fey, MF
Thurlimann, B
Jacky, E
Trinkler, F
Bauer, J
Zulian, G
Hanselmann, S
Hurny, C
Hering, F
Citation: R. Morant et al., Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma, ANN ONCOL, 11(2), 2000, pp. 183-188
Authors:
Crivellari, D
Bonetti, M
Castiglione-Gertsch, M
Gelber, RD
Rudenstam, CM
Thurlimann, B
Price, KN
Coates, AS
Hurny, C
Bernhard, J
Lindtner, J
Collins, J
Senn, HJ
Cavalli, F
Forbes, J
Gudgeon, A
Simoncini, E
Cortes-Funes, H
Veronesi, A
Fey, M
Goldhirsch, A
Citation: D. Crivellari et al., Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: The International Breast Cancer Study Group Trial VII, J CL ONCOL, 18(7), 2000, pp. 1412-1422
Authors:
Coates, AS
Hurny, C
Peterson, HF
Bernhard, J
Castiglione-Gertsch, M
Gelber, RD
Goldhirsch, A
Citation: As. Coates et al., Quality-of-life scores predict outcome in metastatic but not early breast cancer, J CL ONCOL, 18(22), 2000, pp. 3768-3774
Authors:
von Rohr, E
Pampallona, S
van Wegberg, B
Cerny, T
Hurny, C
Bernhard, J
Helwig, S
Heusser, P
Citation: E. Von Rohr et al., Attitudes and beliefs towards disease and treatment in patients with advanced cancer using anthroposophical medicine, ONKOLOGIE, 23(6), 2000, pp. 558-563
Authors:
Sabbioni, MEE
Siegrist, HP
Bacchi, M
Bernhard, J
Castiglione, M
Thurlimann, B
Bonnefoi, H
Perey, L
Herrmann, R
Goldhirsch, A
Hurny, C
Citation: Mee. Sabbioni et al., Association between immunity and prognostic factors in early stage breast cancer patients before adjuvant treatment, BREAST CANC, 59(3), 2000, pp. 279-287
Authors:
von Rohr, E
Pampallona, S
van Wegbeg, B
Hurny, C
Bernhard, J
Heusser, P
Cerny, T
Citation: E. Von Rohr et al., Experiences in the realisation of a research project on anthroposophical medicine in patients with advanced cancer, SCHW MED WO, 130(34), 2000, pp. 1173-1184
Authors:
Ribaudo, HJ
Bacchi, M
Bernhard, J
Thompson, SG
Citation: Hj. Ribaudo et al., A multilevel analysis of longitudinal ordinal data: evaluation of the level of physical performance of women receiving adjuvant therapy for breast cancer, J ROY STA A, 162, 1999, pp. 349-360
Authors:
Bernhard, J
Castiglione-Gertsch, M
Schmitz, SFH
Thurlimann, B
Cavalli, F
Morant, R
Fey, MF
Bonnefoi, H
Goldhirsch, A
Hurny, C
Citation: J. Bernhard et al., Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: Formestane versus megestrol acetate as second-line hormonaltreatment, EUR J CANC, 35(6), 1999, pp. 913-920
Authors:
Sabbioni, MEE
Castiglione, M
Hurny, C
Siegrist, HP
Bacchi, M
Bernhard, J
Thurlimann, B
Bonnefoi, H
Perey, L
Goldhirsch, A
Senn, HJ
Citation: Mee. Sabbioni et al., Interaction of tamoxifen with concurrent cytotoxic adjuvant treatment affects lymphocytes and lymphocyte subsets counts in breast cancer patients, SUPP CARE C, 7(3), 1999, pp. 149-153
Authors:
Bernhard, J
Hurny, C
Maibach, R
Herrmann, R
Laffer, U
Citation: J. Bernhard et al., Quality of life as subjective experience: Reframing of perception in patients with colon cancer undergoing radical resection with or without adjuvantchemotherapy, ANN ONCOL, 10(7), 1999, pp. 775-782
Authors:
Bernhard, J
Thurlimann, B
Schmitz, SFH
Castiglione-Gertsch, M
Cavalli, F
Morant, R
Fey, MF
Bonnefoi, H
Goldhirsch, A
Hurny, C
Citation: J. Bernhard et al., Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: Does quality of life matter?, J CL ONCOL, 17(6), 1999, pp. 1672-1679
Authors:
Huguenin, PU
Bitterli, M
Lutolf, UM
Bernhard, J
Glanzmann, C
Citation: Pu. Huguenin et al., Localized prostate cancer in elderly patients - Outcome after radiation therapy compared to matched younger patients, STRAH ONKOL, 175(11), 1999, pp. 554-558
Risultati:
1-18
|